Guided Therapeutics (GTHP) Other financing activities (2011 - 2026)
Guided Therapeutics (GTHP) posted Other financing activities of -$300000.0 for Q4 2024, down 200.0% sequentially from $300000.0 in Q3 2024, and down 53.85% YoY from -$650000.0 in Q1 2024.
Guided Therapeutics (GTHP) Other financing activities (2011 - 2026) Analysis & Trends
Guided Therapeutics has reported Other financing activities for 9 years, with the latest figure at -$300000.0 in Q4 2024.
- Quarterly Other financing activities fell 53.85% year-over-year to -$300000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2024 was $105000.0 (down 54.74% YoY) and the FY2022 annual result came in at $532000.0, changed N/A from the prior year.
- Other financing activities retreated to -$300000.0 in Q4 2024 per GTHP's latest filing, from $300000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $365000.0 in Q1 2022 and troughed at -$300000.0 in Q4 2024.
- A 4-year average of $66888.9 and a median of $67000.0 in 2020 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 46.58% in 2023, down 627.03% in 2023.
- Over 4 years, Other financing activities stood at $3000.0 in 2020, then jumped by 1133.33% to $37000.0 in 2022, then plunged by 627.03% to -$195000.0 in 2023, then tumbled by 53.85% to -$300000.0 in 2024.
- According to Business Quant data, Other financing activities over the past three periods registered -$300000.0, $300000.0, and -$195000.0 for Q4 2024, Q3 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 980,000.00 |
| Mar 31, 2026 | 980,000.00 |
| Sep 30, 2025 | 260,000.00 |
| Sep 30, 2025 | 260,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Dec 31, 2023 | -195,000.00 |
| Dec 31, 2023 | -195,000.00 |
| Mar 31, 2023 | 195,000.00 |
| Mar 31, 2023 | 195,000.00 |
| Dec 31, 2022 | 37,000.00 |
| Dec 31, 2022 | 37,000.00 |
| Jun 30, 2022 | 130,000.00 |
| Jun 30, 2022 | 130,000.00 |
| Mar 31, 2022 | 365,000.00 |
| Mar 31, 2022 | 365,000.00 |
| Sep 30, 2020 | 3,000.00 |
| Sep 30, 2020 | 3,000.00 |